# Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery

> **NCT00427570** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc**

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** BCG vaccine
- **BIOLOGICAL:** biological therapy
- **DRUG:** fluorouracil
- **DRUG:** semustine
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00427570
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1977-09
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427570, "Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00427570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*